← Open Payments lookup

VY TRAN: Open Payments

NPI 1801108311 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,120 in 128 payments from 17 companies in 2025. Trend: 2023 $2,594 · 2024 $3,453 · 2025 $5,120

Food & beverage: $3,123Consulting: $1,898Education: $99
CompanyPaymentsAmount
Regeneron Pharmaceuticals, Inc.8$1,666
E.R. Squibb & Sons, L.L.C.3$667
Arcutis Biotherapeutics, Inc.27$650
Galderma Laboratories, L.P.14$362
Lilly USA, LLC11$323
LEO Pharma Inc.12$224
Janssen Biotech, Inc.6$221
Incyte Corporation10$210
UCB, Inc.2$208
Novartis Pharmaceuticals Corporation13$199

Products named: DUPIXENT, Zoryve, NEMLUVIO, TREMFYA, OPZELURA, Bimzelx, COSENTYX, EBGLYSS.

Industry payments across OK — which companies pay providers there.